can semaglutide cause colon cancer Association between GLP-1 receptor agonists as a class and colorectal risk: a meta-analysis of retrospective cohort studies | BMC Gastroenterology Ozempic and similar weight-loss drugs

treatment: metformin 2 g/day and insulin glargine 42 IU/day -0.64 IU/kg/day-)

Common side effectsnausea, vomiting, constipation, and loss of appetiteare dose-dependent and often decrease over time as your body adjusts

Clinical Study Report: NN9536-4376 (STEP 4)

Summary Takeaway Messages Despite the ability of GLP-1s to produce significant weight reduction and related health benefits, challenges such as GI side effects, risk of nutrient inadequacies, loss of muscle and bone mass, high costs, frequent discontinuation, and weight regain limit the use of these drugs for long-term success in individuals and populations

Paying hundreds of dollars per month isnt in his budget

In particular, lipase, which is the enzyme that breaks down fats, tends to be reduced, causing problems with digesting fatty foods